James Toler

James Toler is an experienced professional in preclinical and non-clinical outsourcing with a robust background spanning over three decades in the pharmaceutical and biotechnology sectors. Currently serving as Director of Preclinical Outsourcing at Dyne Therapeutics since February 2021, Toler has held several leadership roles, including Associate Director positions at Merck and Wave Life Sciences. Responsibilities include managing vendor communications, strategizing outsourcing initiatives, and ensuring compliance with regulatory standards. Toler's extensive experience at Pfizer involved global outsourcing for in-vivo toxicology projects, where effective project management and collaboration with external partners were key to success. Toler's career began at DuPont RadioPharmaceuticals and has consistently focused on optimizing operations and driving cost-effective solutions within the industry. Education was completed at Franklin Pierce University between 1996 and 2000.